Mahesh V. Patel

CIK: 0001579872

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (71.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LPCN

Lipocine Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

LPCN
Lipocine Inc.
Apr 6, 2026
Purchase(P)
Direct
25K shares at avg. $2.03$51K
LPCN
Lipocine Inc.
Apr 2, 2026
Purchase(P)
Direct
25K shares at avg. $2.02$51K
LPCN
Lipocine Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
25K shares at avg. $8.00-
LPCN
Lipocine Inc.
Dec 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
8.6K shares at avg. $4.20-
LPCN
Lipocine Inc.
Jan 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
16.4K shares at avg. $4.86-
LPCN
Lipocine Inc.
Dec 23, 2024
Award(A)
Stock Option (Right to Buy)
Direct
10.3K shares at avg. $4.80-
LPCN
Lipocine Inc.
Dec 23, 2024
Award(A)
Stock Option (Right to Buy)
Direct
26.7K shares at avg. $4.80-

		Type	Shares	Price		Ownership
Apr 6, 2026	LPCN Lipocine Inc.	Purchase(P)	25,000	$2.03	$50,750	Direct
Apr 2, 2026	LPCN Lipocine Inc.	Purchase(P)	25,000	$2.02	$50,500	Direct
Jan 2, 2026	LPCN Lipocine Inc.	Award(A) Stock Option (Right to Buy)	25,000	$8.00	-	Direct
Dec 18, 2025	LPCN Lipocine Inc.	Award(A) Stock Option (Right to Buy)	8,629	$4.20	-	Direct
Jan 2, 2025	LPCN Lipocine Inc.	Award(A) Stock Option (Right to Buy)	16,371	$4.86	-	Direct
Dec 23, 2024	LPCN Lipocine Inc.	Award(A) Stock Option (Right to Buy)	10,320	$4.80	-	Direct
Dec 23, 2024	LPCN Lipocine Inc.	Award(A) Stock Option (Right to Buy)	26,691	$4.80	-	Direct

1-7 of 7 transactions

About Patel Mahesh V.

Patel Mahesh V. (SEC CIK 0001579872) files insider reports with the SEC as Chief Executive Officer of Lipocine Inc. (LPCN).

Signal8 holds 7 ownership filings by Patel Mahesh V., all Form 4s, filed between Dec 30, 2024 and Apr 6, 2026. Those filings report 7 transactions, from Dec 23, 2024 to Apr 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Patel Mahesh V.'s filings is in SALT LAKE CITY, UT.

Recent filings by Patel Mahesh V.

Apr 6, 2026: Open-market purchase of LPCN shares (Form 4, code P).
Apr 2, 2026: Open-market purchase of LPCN shares (Form 4, code P).
Jan 2, 2026: Grant or award of LPCN derivative securities (Form 4, code A).
Dec 18, 2025: Grant or award of LPCN derivative securities (Form 4, code A).
Jan 2, 2025: Grant or award of LPCN derivative securities (Form 4, code A).

Other insiders filing for Lipocine Inc. (LPCN)

Higuchi John W., Director
Grissinger Michael, Director
Jene Jill M., Director
Ono Richard Dana, Director
Fogarty Krista, Principal Accounting Officer
Papapetropoulos Spyros, Director

How to read Form 4 transaction codes